‘Months Of Activity’ Lost By Notified Bodies: New EU Measures May Be Needed
Executive Summary
The European Commission has admitted that MDR implementation has been severely compromised by COVID-19, and potential delays in notified body conformity assessment of products must be addressed to avoid device shortages for patients.
You may also be interested in...
Latest MDR Guidances: Vital Clinical Evidence Documents And Timely Ventilator Requirements
Clinical evidence requirements are much tighter under the EU Medical Device Regulation. Now there is help in addressing these requirements as April sees the publication of a flood of seven guidance documents in total intended to help manufacturers comply with the MDR.
Guidance Clarifies EU Position On Alternatives To Notified Body On-Site Audits
Virtual notified body audits of medtech manufacturers are already taking place through necessity. Now there is guidance concerning if, when, where and how these audits should be carried out.
Commission Provides Regulatory Advice For COVID-19 Medtech Sector Entrants Amid Counterfeit Concerns
A new European Commission guidance document explains the regulatory basics and emergency market entry criteria for new entrants to the devices sector amid the COVID-19 crisis.